Bancel Stephane
Chief Executive Officer
Bancel Stephane has filed 4 SEC Form 4 filings (10 transaction rows) across 2 companies, including MRNA, GENB, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Bancel Stephane is listed as Chief Executive Officer at Moderna, Inc. Inside the rolling window, Bancel Stephane reported no open-market purchases and 1 open-market sale totaling $28.7M in MRNA.
Companies traded
Other insiders at MRNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$28.7M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bancel Stephane made?
Bancel Stephane has filed 4 SEC Form 4 filings (10 transaction rows) across 2 companies, including MRNA, GENB since 2025.
Which companies does Bancel Stephane trade?
Bancel Stephane has filed SEC Form 4 disclosures for 2 companies, including MRNA, GENB.
When was Bancel Stephane's most recent SEC Form 4 filing?
Bancel Stephane's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Bancel Stephane's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bancel Stephane is listed as Chief Executive Officer.
What is Bancel Stephane's total buy and sell value in the current window?
Inside the rolling retention window, Bancel Stephane bought $0 and sold $28.7M based on SEC Form 4 filings.
What was Bancel Stephane's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 499,246 MRNA shares on 2026-08-05, worth $28.7M, per SEC Form 4 filings.